Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03088384 · ClinicalTrials.gov registry record
Ketamine Infusion Therapy for PTSD in Combat Veterans
A clinical trial of Stress Disorders, Post-Traumatic, sponsored by Klarisana Physician Services P.
- Completed
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT03088384: Completed study of Stress Disorders, Post-Traumatic, sponsored by Klarisana Physician Services P.
NCT03088384 is a study of Stress Disorders, Post-Traumatic that has completed, run by Klarisana Physician Services P. The registered enrollment target is 30 participants, below the 156-participant average among 66 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03088384, a study of Stress Disorders, Post-Traumatic, has completed, sponsored by Klarisana Physician Services P.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Klarisana is conducting an observational study in San Antonio, Texas to see if there are tangible improvements in the symptoms of post traumatic stress disorder (PTSD) in combat veterans after receiving a series of six low-dose outpatient infusions of ketamine.
Primary Outcome
The PCL-5 is a twenty question survey instrument which is used to quantify the level of symptomatology in participants with post-traumatic stress disorder.
Conditions Studied
Interventions
- DRUG Ketamine
Study Locations (1)
Texas
- Klarisana - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2016-11-28 |
| Est. Completion | 2018-09-29 |
What the finished NCT03088384 record still lists
NCT03088384 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 156-participant average among 66 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (81% lower).
The record links to 1 condition, with Stress Disorders, Post-Traumatic appearing as the primary indexed condition, and to 1 intervention - of which Ketamine is the first listed.
NCT03088384 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT03088384 about?
NCT03088384 is a clinical study titled "Ketamine Infusion Therapy for PTSD in Combat Veterans". Klarisana is conducting an observational study in San Antonio, Texas to see if there are tangible improvements in the symptoms of post traumatic stress disorder (PTSD) in combat veterans after receiving a series of six low-dose outpatient infusions of ketamine.
What is the current status of trial NCT03088384?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2016-11-28. Estimated completion is 2018-09-29.
What conditions does trial NCT03088384 study?
This clinical trial studies the following conditions: Stress Disorders, Post-Traumatic.
What interventions are being tested in trial NCT03088384?
The interventions under investigation include: Ketamine (DRUG).
Who is sponsoring clinical trial NCT03088384?
This trial is sponsored by Klarisana Physician Services P, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03088384 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stress Disorders, Post-Traumatic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03088384's enrollment target sits among peer trials
30 57th of 66 higher than 7 of 66 other Stress Disorders, Post-Traumatic trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stress Disorders, Post-Traumatic trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Manage Emotions to Reduce Aggression (MERA)
RECRUITING · NA
-
SMART Therapist Training: A Hybrid Factorial-SMART Design
RECRUITING · NA
-
Overcontrol and Suicide in PTSD
RECRUITING
-
Postpartum Care in the NICU (PeliCaN) Transitions
RECRUITING · NA
-
Healthy Recovery After Trauma Study
RECRUITING · NA
-
MDMA for Co-occurring PTSD and OUD After Childbirth
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI